DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



A Prospective Study Evaluating the Integration Success and Maintenance of Short Length NanoTite Dental Implants Into Maxillary Sites That Would Otherwise Require Sinus Augmentation.

Information source: Biomet, Inc.
Information obtained from ClinicalTrials.gov on November 03, 2008
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Dental Implants; Edentulism

Intervention: Dental Implant (Nanotite) (Device); Dental implant Nanotite (Device)

Phase: N/A

Status: Not yet recruiting

Sponsored by: Biomet 3i, LLC

Official(s) and/or principal investigator(s):
Mariano A Sanz, MD, DDS, Principal Investigator, Affiliation: Universidad Complutense de Madrid

Summary

This prospective randomized study will evaluate the integration success while supporting a prosthesis for short implants placed into maxillary sites having minimal bone height that would otherwise need sinus augmentation. The resources utilized during treatment will be assessed.

Study (null) hypothesis: the overall benefit of using short length implants to avoid sinus augmentation procedures will offset differences in the cumulative implant survival rates observed between treatment groups.

Clinical Details

Official title: A Prospective, Multicenter, Randomized-Controlled Multicenter Study of the Use of Short Implants to Obviate the Need for Sinus Augmentation: an Assessment of Clinical Outcomes and Resource Allocation.

Study design: Treatment, Randomized, Open Label, Placebo Control, Parallel Assignment, Safety/Efficacy Study

Primary outcome: Integration success of implant

Secondary outcome: Cost analysis

Detailed description: In this randomized study, patients needing restorations in the posterior maxilla will be randomly assigned to the short implant group (test) or the standard length and augmentation group (control). All implants will be placed using a two-stage approach with healing abutments placed at three months and temporary prosthesis at four months following implant and/ or sinus augmentation surgery. Time, materials, and efforts associated with treating test and control cases will be documented to allow an assessment of the costs incurred with each approach.

Eligibility

Minimum age: 18 Years. Maximum age: N/A. Gender(s): Both.

Criteria:

Inclusion Criteria:

- patients of either sex and any race greater than 18 years of age

- patients with partial edentulism in the posterior maxilla requiring a unilateral

implant-supported maxillary prosthesis

- patients with a residual alveolar floor of the sinus between 4 and 6 mm in height, as

assessed on intraoral radiographs, and able to receive at least a 4mm wide implant

- patients must be physically able to tolerate conventional surgical and restorative

procedures

Exclusion Criteria:

- patients with active infection or severe inflammation in the areas intended for

implant placement

- patients with a > 10 cigarettes per day smoking habit

- patients with uncontrolled diabetes or metabolic bone disease

- patient with a history of therapeutic radiation to the head

- patients who are known to be pregnant

- patients with para-functional habits with evidence of severe bruxing or clenching

- patients not able to commit to a 3 year follow-up program

Locations and Contacts

Universidad Complutense de Madrid, Madrid 28040, Spain
Additional Information

Starting date: September 2008
Ending date: October 2012
Last updated: July 28, 2008

Page last updated: November 03, 2008

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009